PascalFr.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « PascalFr.i » - entrée « Bromocriptine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Bradykinésie < Bromocriptine < Bromure d'ipratropium  Facettes :

List of bibliographic references indexed by Bromocriptine

Number of relevant bibliographic references: 14.
Ident.Authors (with country if any)Title
003802 (1999) P. J. Blanchet [Canada]Rationale for use of dopamine agonists in Parkinson's disease : Review of ergot derivatives
003C66 (1997) M. Guttman [Canada]Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease
003F76 (1995) Céline Gagnon [Canada] ; Baltazar Gomez-Mancilla [Canada] ; Rudolf Markstein [Suisse] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Effect of adding the D-1 agonist CY 208–243 to chronic bromocriptine treatment of MPTP-monkeys: Regional changes of brain dopamine receptors
004453 (1993) B. Gomez-Mancilla [Canada] ; R. Boucher ; C. Gagnon ; T. Di Paolo ; R. Markstein ; P. J. BedardEffect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors
004630 (1992) H. A. Robertson [Canada] ; M. R. Peterson ; G. G. WorthSynergistic and persistent interaction between the D2 agonist, bromocriptine, and the D1 selective agonist, CY 208-243
004897 (1990) C. Rouillard [Canada] ; P. J. Bédard [Canada] ; T. Di Paolo [Canada]Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393
004899 (1990) Céline Gagnon [Canada] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Effect of chronic treatment of MPTP monkeys with dopamine D-1 and/or D-2 receptor agonists
004C61 (1988) P. Falardeau ; S. Bouchard ; P. J. Bedard ; R. Boucher ; T. Di PaoloBehavioral and biochemical effect of chronic treatment with D-1 and/or D-2dopamine agonists in MPTP monkeys
004D09 (1987) Anthony E. Lang [Canada]Manipulating the dopaminergic system in Parkinson's disease
004D90 (1987) H. A. Robertson ; G. S. RobertsonHypothesis. Combined L-dopa and bromocriptine therapy for Parkinson's disease: a proposed mechanism of action
004E01 (1987) I. Libman ; M. J. Gawel ; R. J. Riopelle ; S. BouchardA comparison of bromocriptine (Parlodel®) and levodopa-carbidopa (Sinemet®) for treatment of "De Novö Parkinson's disease patients
004F09 (1986) P. J. Bedard ; T. Di Paolo ; P. Falardeau ; R. BoucherChronic treatment with L-DOPA, but not bromocriptine induces dyskinesia in MPTP-Parkinsonian monkeys. Correlation with [3H]spiperone binding
005032 (1984) T. A. Larsen ; R. Newman ; P. Lewitt ; D. B. CalneSeverity of Parkinsońs disease and the dosage of bromocriptine
005037 (1984) J. D. Grimes ; D. B. King ; O. S. Kofman ; P. Molina-Negro ; A. F. Wilson ; S. BouchardBromocriptine in the management of end of dose deterioration in Parkinson's disease

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Bromocriptine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i  \
                -Sk "Bromocriptine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Bromocriptine
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022